CelluSTAT
NDA- Indications
- Surgical bleeding control, Dialysis bleeding, Dental bleeding, Emergency medicine bleeding
Company intelligence / Profile preview
United Health Products manufactures CelluSTAT™ Absorbable Hemostat, a sterile hemostatic gauze derived from plant cellulose. The product accelerates hemostasis in mild to moderate bleeds and has been submitted for FDA Premarket Approval as of March 2024. Clinical results are not yet public; the product remains unavailable for sale pending regulatory approval.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on United Health Products.